Malaysia Biotech CCM Duopharma Announces Expansion Plans
This article was originally published in PharmAsia News
Executive Summary
Malaysia's CCM Duopharma Biotech says it plans to spend $23.1 million over the next three years to expand its plant to accommodate its growth expectations. In addition to expanding its production capacity, CCMD also plans to buy new machinery, upgrade amenities and improve its warehousing and waste-water treatment facilities. The result, it says, should be increased capacity for producing injectables, liquids and ampule-packing capacity. (Click here for more